A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The Phase I portion of this protocol will determine the best phase II dose and schedule of obatoclax with carboplatin and etoposide in patients with extensive-stage small cell lung cancer. The Phase II portion will evaluate the response rate to this regimen.
Epistemonikos ID: 237d8b4927cd403bdb761a9189ad95899fa35612
First added on: May 05, 2024